New serum biomarkers for detection of esophageal carcinoma using matrix-assisted laser desorption/ionization time-of-xight mass spectrometry

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 3, 2011, Pages 513-519

  Guo, Renyong ^a   Pan, Chunqin ^b   Shen, Jianmin ^b   Liu, Chibo ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Biomarker; Esophageal carcinoma; MALDI; Protein

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ESOPHAGUS CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

BLOOD PROTEINS; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MAGNETICS; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; PEPTIDE MAPPING; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79954439353     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0899-3     Document Type: Article

References (27)

1. Alibakhshi A, Aminian A, Mirsharifi R, Jahangiri Y, Dashti H, Karimian F (2009) The effect of age on the outcome of esophageal cancer surgery. Ann Thorac Med 4:71-74
2. Besharat S, Jabbari A, Semnani S, Keshtkar A, Marjani J (2008) Inoperable esophageal cancer and outcome of palliative care. World J Gastroenterol 14:3725-3728
3. Cho WC (2006) Research progress in SELDI-TOF MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 22:871-876
4. Cho WC (2007) Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6:25
5. Cho WC, Cheng CH (2007) Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics 4:401-410 (Pubitemid 46890077)
6. Cho WC, Yip TT, Ngan RK, Yip TT, Podust VN (2007) ProteinChip array profiling for identification of disease-and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin Chem 53:241-250 (Pubitemid 46338268)
7. Conrads TP, Hood BL, Issaq HJ, Veenstra TD (2004a) Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Mol Diagn 8:77-85 (Pubitemid 39363461)
8. Conrads TP, Fusaro VA, Ross S (2004b) High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer 11:163-178 (Pubitemid 38832824)
9. Crew KD, Neugut AI (2004) Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31:450-464 (Pubitemid 39070265)
10. Internullo E, Moons J, Nafteux P, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Lerut T (2008) Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg 33:1096-1104
11. Jacobs IJ, Menon U (2004) Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics 3:355-366 (Pubitemid 38702089)
12. Kohonen T (2006) Self-organizing neural projections. Neural Netw 19:723-733 (Pubitemid 44148941)
13. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN (2003) Identification of biomarkers for ovarian cancer using strong anionexchange ProteinChips: potential use in diagnosis and prognosi. Proc Natl Acad Sci USA 100:12343-12348 (Pubitemid 37271562)
14. Langbein S, Lehmann J, Harder A, Steidler A, Michel MS (2006) Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat 5:67-72
15. Linke T, Doraiswamy S, Harrison EH (2007) Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 849:273-281 (Pubitemid 46529327)
16. Liu CB, Liang Y, Pan CQ et al (2009) Proteome study of differential protein expression in HBV-related primary hepatic carcinoma. Chem J Chinese Universities 30:1763-1766
17. Malik G, Ward MD, Gupta SK, Trosset MW, Grizzle WE (2005) Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 11:1073-1085 (Pubitemid 40175756)
18. Menon U, Jacobs IJ (2000) Recent developments in ovarian cancer screening. Curr Opin Obstet Gynecol 12:39-42 (Pubitemid 32260287)
19. Paradis V, Degos F, Dargère D, Pham N, Belghiti J (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41:40-47 (Pubitemid 40066381)
20. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
21. Petricoin EFL, Liotta LA (2004) SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 15:24-30 (Pubitemid 38224245)
22. Rodland KD (2004) Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin Biochem 37:579-583 (Pubitemid 38849421)
23. Ruol A, Portale G, Zaninotto G, Cagol M, Cavallin F, Castoro C, Sileni VC, Alfieri R, Rampado S, Ancona E (2007) Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg 133:1186-1192 (Pubitemid 46635508)
24. Walsh PC (2003) Serum proteomic patterns for detection of prostate cancer. J Urol 169:1592
25. Wulfkuhle JD, Liotta LA, Petricoin EF (2003) Proteomic applications for the early detection of cancer. Nat Rev Cancer 3:267
26. Zeidan BA, Townsend PA (2008) SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 10:107
27. Zhu LR, Zhang WY, Yu L, Zheng YH, Zhang JZ, Liao QP (2006) Serum proteomic features for detection of endometrial cancer. Int J Gynecol Cancer 16:1374-1378 (Pubitemid 43886772)